Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

LentiV_Blast Citations (3)

Originally described in: Salt-Inducible Kinase inhibition suppresses acute myeloid leukemia progression in vivo.
Tarumoto Y, Lin S, Wang J, Milazzo JP, Xu Y, Lu B, Yang Z, Wei Y, Polyanskaya S, Wunderlich M, Gray NS, Stegmaier K, Vakoc CR Blood. 2019 Nov 1. pii: 422697. doi: 10.1182/blood.2019001576.
PubMed Journal

Articles Citing LentiV_Blast

Articles
ZMYND8-regulated IRF8 transcription axis is an acute myeloid leukemia dependency. Cao Z, Budinich KA, Huang H, Ren D, Lu B, Zhang Z, Chen Q, Zhou Y, Huang YH, Alikarami F, Kingsley MC, Lenard AK, Wakabayashi A, Khandros E, Bailis W, Qi J, Carroll MP, Blobel GA, Faryabi RB, Bernt KM, Berger SL, Shi J. Mol Cell. 2021 Sep 2;81(17):3604-3622.e10. doi: 10.1016/j.molcel.2021.07.018. Epub 2021 Aug 5. PubMed

Associated Plasmids

Cloning BRD4 long isoform into overexpression vectors for stable overexpression of BRD4-L in mammalian cells. Drumond-Bock AL, Cybula M, Wang L, Wang L, Bieniasz M. STAR Protoc. 2022 Oct 26;3(4):101785. doi: 10.1016/j.xpro.2022.101785. eCollection 2022 Dec 16. PubMed
Increased expression of BRD4 isoforms long (BRD4-L) and short (BRD4-S) promotes chemotherapy resistance in high-grade serous ovarian carcinoma. Drumond-Bock AL, Wang L, Wang L, Cybula M, Rostworowska M, Kinter M, Bieniasz M. Genes Cancer. 2023 Sep 12;14:56-76. doi: 10.18632/genesandcancer.233. eCollection 2023. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.